Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Journal of Alzheimer'S Disease : JAD|June 15, 2014
Positive florbetapir PET amyloid imaging in a subject with frequent cortical neuritic plaques and frontotemporal lobar degeneration with TDP43-positive inclusionsGeidy E Serrano, Marwan N Sabbagh, Lucia I Sue, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 27, 2010
In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18)Dean F Wong, Paul B Rosenberg, Yun Zhou, et al.
Seminars in Nuclear Medicine|June 1, 2011
Florbetapir f-18: a histopathologically validated Beta-amyloid positron emission tomography imaging agentJohn Lister-James, Michael J Pontecorvo, Chris Clark, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 15, 2012
Performance characteristics of amyloid PET with florbetapir F 18 in patients with alzheimer's disease and cognitively normal subjectsAbhinay D Joshi, Michael J Pontecorvo, Chrisopher M Clark, et al.
Journal of Alzheimer'S Disease : JAD|March 15, 2021
Clinicopathological Correlation: Dopamine and Amyloid PET Imaging with Neuropathology in Three Subjects Clinically Diagnosed with Alzheimer's Disease or Dementia with Lewy BodiesHarsh V Gupta, Thomas G Beach, Shyamal H Mehta, et al.
Brain : a Journal of Neurology|April 23, 2019
A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer's disease dementiaMichael J Pontecorvo, Michael D Devous, Ian Kennedy, et al.
Neurobiology of Aging|August 11, 2012
Amyloid deposition detected with florbetapir F 18 ((18)F-AV-45) is related to lower episodic memory performance in clinically normal older individualsReisa A Sperling, Keith A Johnson, P Murali Doraiswamy, et al.
Neurology|July 13, 2012
Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter studyP Murali Doraiswamy, Reisa A Sperling, R Edward Coleman, et al.
Neurobiology of Aging|May 29, 2012
Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer diseaseAdam S Fleisher, Kewei Chen, Xiaofen Liu, et al.
The Lancet. Neurology|July 4, 2012
Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort studyChristopher M Clark, Michael J Pontecorvo, Thomas G Beach, et al.
Pageof 4